arrow
L

Lye Mun Tho

beacon hospital
H指数:18
被引数:5,519

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation–positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA study

达可替尼作为亚洲表皮生长因子受体(EGFR)突变阳性局部晚期或转移性非小细胞肺癌患者的一线疗法:ARIA研究的最终分析

2025-11-250
PRE
Tepotinib Plus an EGFR Tyrosine Kinase Inhibitor in Patients With EGFR-Mutant MET-Altered NSCLC: A Case Series

Tepotinib联合EGFR酪氨酸激酶抑制剂在EGFR突变、MET改变的NSCLC患者中的应用:一项病例系列研究

2025-02-210
PRE
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial
2024-12-011
OAAI
Tepotinib plus osimertinib in EGFR-mutant NSCLC with MET amplification following first-line osimertinib: INSIGHT 2 primary analysis
2023-12-011
PRE
INSIGHT 2: a Phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance

见解2: tepotinib联合奥希替尼治疗MET扩增的NSCLC和一线奥希替尼耐药的II期研究

2021-12-1739
OA